← All trials
NCT04886986
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2021
- Primary completion
- Dec 24, 2024
- Completion date
- Dec 27, 2027
- First posted
- May 14, 2021
- Last posted
- Aug 18, 2021
- Enrollment
- 33
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cornell UniversityLead sponsor
- Cornell UniversityOverall official - principal investigator
- POINT BiopharmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.